[Immunologic abnormalities during treatment with penicillamine].
D000328:Adult; D000368:Aged; D000906:Antibodies / Q000032:analysis; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology; D001323:Autoantibodies / Q000032:analysis; D001792:Blood Platelets / Q000276:immunology; D005260:Female; D006801:Humans; D007158:Immunologic Techniques; D008214:Lymphocytes / Q000187:drug effects* / Q000276:immunology; D008233:Lymphotoxin-alpha / Q000032:analysis; D008297:Male; D008875:Middle Aged; D009504:Neutrophils; D010396:Penicillamine / Q000009:adverse effects* / Q000627:therapeutic use
D000906:Antibodies; D001323:Autoantibodies; D008233:Lymphotoxin-alpha; D010396:Penicillamine
A propos d'anomalies immunologiques au cours de traitements par pénicillamine